KHOSLA CHAITAN PHD 4
4 · Protagonist Therapeutics, Inc · Filed Apr 2, 2019
Insider Transaction Report
Form 4
KHOSLA CHAITAN PHD
Director
Transactions
- Award
Stock Option (right to buy)
2018-05-15+3,000→ 3,000 totalExercise: $6.45Exp: 2028-05-14→ Common Stock (3,000 underlying)
Footnotes (1)
- [F1]The stock option vests in 12 equal monthly installments following the date of grant.